1 hour ago
2
Soumya Eswaran
Mon, June 22, 2026 astatine 9:39 AM CDT 3 min read
Grow Funds, an concern Advisor, released its Q1 2026 capitalist missive for "GROW Small Cap Equity Long/Short Fund". A transcript of the missive tin beryllium downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index's –2.80%, HFRI Equity Hedge Index's -0.24%, and the HFRI Fundamental Growth Index's 0.47% returns. Long positions and hedges, and abbreviated positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.
In its first-quarter 2026 capitalist letter, Grow Funds highlighted Paysign, Inc. (NASDAQ:PAYS). Paysign, Inc. (NASDAQ:PAYS) is simply a fiscal exertion institution specializes successful prepaid paper programs, diligent affordability offerings, integer banking, beingness subject bundle exertion solutions, and integrated outgo processing services. On June 18, 2026, Paysign, Inc. (NASDAQ:PAYS) closed astatine $7.40 per share. One-month instrumentality of Paysign, Inc. (NASDAQ:PAYS) was 10.12%, and its shares gained 35.78% implicit the past 52 weeks. Paysign, Inc. (NASDAQ:PAYS) has a marketplace capitalization of $413.70 million.
Grow Funds stated the pursuing regarding Paysign, Inc. (NASDAQ:PAYS) successful its Q1 2026 capitalist letter:
"Paysign, Inc. (NASDAQ:PAYS) operates a vertically integrated prepaid paper outgo solutions and processing business, chiefly serving the pharmaceutical and healthcare sectors. The institution manages the full prepaid paper lifecycle—design, issuance, and processing—generating gross done transaction fees, cardholder fees, programme absorption fees, and funds breakage. Paysign banal had underperformed importantly successful January and February owed to AI fears and pharmaceutical disruption from the Trump Administration. On March 24th, PAYS reported their Q4 2025 Earnings which proved these fears to beryllium overblown. They bushed expectations importantly connected the apical and bottommost lines arsenic good arsenic raised guidance for 2026. The banal remains inexpensive astatine 7x EV/EBITDA portion increasing revenues 40% past year. We judge this trajectory tin proceed arsenic absorption executes. With their excess cashflow, we judge PAYS could statesman paying a dividend oregon buying backmost shares to instrumentality superior to shareholders."
Paysign, Inc. (NASDAQ:PAYS) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 14 hedge money portfolios held Paysign, Inc. (NASDAQ:PAYS) astatine the extremity of the archetypal quarter, compared to 18 successful the erstwhile quarter. In Q1 2026, Paysign, Inc.'s (NASDAQ:PAYS) gross grew 50.8% to $28 million. While we admit the imaginable of Paysign, Inc. (NASDAQ:PAYS) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·